The Major Factors to Rise in Biosimilar Insulin Market: Find the Overview and Its Impact in the Future
A biosimilar product is a replica of a biological molecule that is already approved in the pharmaceutical market. At best they are very similar to the original product. The key question that still has to be answered is whether the minor differences between an insulin copy and the original insulin are clinically relevant. Until now, most of the insulin used has been manufactured by a small number of companies, each manufacturing their own insulin formulation that was patented years back.
View full press release